Paola Yvroud-Hoyos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paola Yvroud-Hoyos has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Mathilde Touvier
Université Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Center of Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN), Bobigny, France
3 shared publications Alexandre De Sa
Université Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre for Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN) , 74 rue Marcel Cachin, 93017 Bobigny, Seine-Saint-Denis
2 shared publications- Anaïs Hasenböhler
Université Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre for Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN) , 74 rue Marcel Cachin, 93017 Bobigny, Seine-Saint-Denis
2 shared publications - Benjamin Allès
Université Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre for Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN), Bobigny, France
2 shared publications - Benoit Chassaing
Microbiome-Host Interactions, Institut Pasteur, Université Paris Cité, INSERM U1306, Paris, France
2 shared publications - Bernard Srour
Université Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre for Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN), Bobigny, France
2 shared publications
Latest Publications
- Open Access
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Higher Dispositional Mindfulness Is Associated with Lower Risk of Type 2 Diabetes in Women: A Large Prospective Cohort Study
Background: Type 2 diabetes (T2D) is a growing public health concern worldwide. Beyond well-established lifestyle and health risk factors, psychosocial characteristics, such as dispositional mindfulness, have been proposed as potential protective factors. However, prospective evidence remains limited. This study investigates prospective association between dispositional mindfulness and T2D incidence.Methods: We included 63,336 adults (mean age: 48.2 ± 14.6 years; 78.8 % women) from the French NutriNet-Santé cohort without T2D at baseline. Dispositional mindfulness was assessed in 2013 using the validated French Five Facets Mindfulness Questionnaire. Incident T2D cases were identified during the follow-up. Cox proportion hazard models, stratified for sex, were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), adjusting for sociodemographic and family history of TD2. Mediation analyses assessed the contribution of diet quality, physical activity, and BMI.Findings: During a median follow-up of 9 years (505,714 person-years), 1,011 incident T2D cases were identified. Higher dispositional mindfulness was associated with a lower T2D incidence in women (HR per 1-point increase = 0.66 [0.55–0.80], p<0.001), but not in men (HR = 0.91 [0.71 – 1.17], p=0.46) (p-interaction = 0.031). In women, diet quality (8.1% [6.2–10.3], p<0.001), physical activity (10.1% [5.1–23.6], p<0.001), and BMI (21.4% [10.8–89.5], p<0.001) accounted of the association.Interpretation: Higher dispositional mindfulness was associated with lower T2D incidence in women, partly mediated by diet quality, physical activity, and BMI. Mindfulness may represent a complementary target for diabetes prevention.
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHigher Dispositional Mindfulness Is Associated with Lower Risk of Type 2 Diabetes in Women: A Large Prospective Cohort Study
Background: Type 2 diabetes (T2D) is a growing public health concern worldwide. Beyond well-established lifestyle and health risk factors, psychosocial characteristics, such as dispositional mindfulness, have been proposed as potential protective factors. However, prospective evidence remains limited. This study investigates prospective association between dispositional mindfulness and T2D incidence.Methods: We included 63,336 adults (mean age: 48.2 ± 14.6 years; 78.8 % women) from the French NutriNet-Santé cohort without T2D at baseline. Dispositional mindfulness was assessed in 2013 using the validated French Five Facets Mindfulness Questionnaire. Incident T2D cases were identified during the follow-up. Cox proportion hazard models, stratified for sex, were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), adjusting for sociodemographic and family history of TD2. Mediation analyses assessed the contribution of diet quality, physical activity, and BMI.Findings: During a median follow-up of 9 years (505,714 person-years), 1,011 incident T2D cases were identified. Higher dispositional mindfulness was associated with a lower T2D incidence in women (HR per 1-point increase = 0.66 [0.55–0.80], p<0.001), but not in men (HR = 0.91 [0.71 – 1.17], p=0.46) (p-interaction = 0.031). In women, diet quality (8.1% [6.2–10.3], p<0.001), physical activity (10.1% [5.1–23.6], p<0.001), and BMI (21.4% [10.8–89.5], p<0.001) accounted of the association.Interpretation: Higher dispositional mindfulness was associated with lower T2D incidence in women, partly mediated by diet quality, physical activity, and BMI. Mindfulness may represent a complementary target for diabetes prevention.
- Open Access
- 20 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (39) , 5788-5804
Preservative food additives, hypertension, and cardiovascular diseases: the NutriNet-Santé study
Background and Aims: Experimental studies suggest that some preservative food additives may exert adverse cardiovascular effects, yet human data are lacking. The associations between exposure to these compounds and incidence of hypertension and cardiovascular diseases (CVD) were investigated in the NutriNet-Santé cohort (France, 2009–2024). Methods: Dietary intakes were assessed using repeated 24-h dietary records (up to 96), including commercial brands. Exposure to food additives was evaluated through multiple composition databases and ad hoc laboratory assays in food matrices. Associations between cumulative time-dependent exposures to preservative food additives during follow-up and outcomes were characterized using multi-adjusted Cox models. Results: Overall, 112 395 participants were included (78.7% women, mean age 42.8 ± 14.7 years) with a median follow-up of 7.9 years. The sum of total preservatives encompassed 58 substances consumed by at least one participant. Total non-antioxidant preservatives were positively associated with higher incidences of hypertension [n = 5544; hazard ratio (HR) higher vs. lower consumers: 1.29, 95% confidence interval (CI) 1.20–1.39] and CVD (n = 2450; HR 1.16, 95% CI 1.04–1.29), while total antioxidant preservatives were associated with higher incidence of hypertension (HR 1.22, 95% CI 1.13–1.31). Out of the 17 individual preservative food additives consumed by at least 10% of the study population, eight were associated with higher incidence of hypertension and one with higher incidence of CVD, after multiple test correction. Conclusions: Multiple associations between exposure to preservative food additives widely used in industrial foods and higher incidence of hypertension or CVD were observed in this large prospective cohort. Experimental research is needed to gain insight into underlying mechanisms. If confirmed, these new data call for the re-evaluation of regulations governing the use of these additives to improve consumer protection. Trial Registration: ClinicalTrials.gov NCT03335644.
- 20 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (39) , 5788-5804
Open AccessPreservative food additives, hypertension, and cardiovascular diseases: the NutriNet-Santé study
Background and Aims: Experimental studies suggest that some preservative food additives may exert adverse cardiovascular effects, yet human data are lacking. The associations between exposure to these compounds and incidence of hypertension and cardiovascular diseases (CVD) were investigated in the NutriNet-Santé cohort (France, 2009–2024). Methods: Dietary intakes were assessed using repeated 24-h dietary records (up to 96), including commercial brands. Exposure to food additives was evaluated through multiple composition databases and ad hoc laboratory assays in food matrices. Associations between cumulative time-dependent exposures to preservative food additives during follow-up and outcomes were characterized using multi-adjusted Cox models. Results: Overall, 112 395 participants were included (78.7% women, mean age 42.8 ± 14.7 years) with a median follow-up of 7.9 years. The sum of total preservatives encompassed 58 substances consumed by at least one participant. Total non-antioxidant preservatives were positively associated with higher incidences of hypertension [n = 5544; hazard ratio (HR) higher vs. lower consumers: 1.29, 95% confidence interval (CI) 1.20–1.39] and CVD (n = 2450; HR 1.16, 95% CI 1.04–1.29), while total antioxidant preservatives were associated with higher incidence of hypertension (HR 1.22, 95% CI 1.13–1.31). Out of the 17 individual preservative food additives consumed by at least 10% of the study population, eight were associated with higher incidence of hypertension and one with higher incidence of CVD, after multiple test correction. Conclusions: Multiple associations between exposure to preservative food additives widely used in industrial foods and higher incidence of hypertension or CVD were observed in this large prospective cohort. Experimental research is needed to gain insight into underlying mechanisms. If confirmed, these new data call for the re-evaluation of regulations governing the use of these additives to improve consumer protection. Trial Registration: ClinicalTrials.gov NCT03335644.
- Top Cited PapersOpen Access
Intake of food additive preservatives and incidence of cancer: results from the NutriNet-Santé prospective cohort
Objective: To investigate the association between intake of food additive preservatives and cancer incidence in a large prospective cohort. Design: Prospective cohort. Setting: French NutriNet-Santé cohort, 2009-23. Participants: 105 260 participants (≥15 years) without prevalent cancer who completed at least two 24 hour dietary records at baseline. Main outcome measures: Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed using repeated 24 hour dietary records and evaluated through multiple composition databases and ad hoc laboratory assays in food products for the most frequently consumed additive-food pairs. Associations between intake of three categories of preservatives (defined as sex specific thirds if preservative was consumed by at least a third of participants, otherwise defined as non-consumers and lower or higher consumers separated by the sex specific median) and cancer incidence were characterised using multivariable proportional hazards Cox models adjusted for potential confounders. Results: Mean age of participants was 42.0 years (standard deviation (SD 14.5) years), and 78.7% were women. 4226 participants received a diagnosis of incident cancer (mean follow-up 7.57 (SD 4.56) years), comprising 1208 breast, 508 prostate, 352 colorectal, and 2158 other cancers). Higher intakes of several preservatives were associated with higher cancer incidence: total non-antioxidants with overall cancer (hazard ratio for higher v non-consumers or lower consumers 1.16 (95% confidence interval (CI) 1.07 to 1.26); absolute risk of cancer at age 60 years, respectively, 13.3%, 12.1%) and breast cancer (1.22 (1.05 to 1.41); 5.7%, 4.8%); total sorbates, specifically potassium sorbate, with overall cancer (1.14 (1.04 to 1.24); 13.4%, 11.8%) and breast cancer (1.26 (1.07 to 1.49); 5.7%, 4.6%); total sulfites with overall cancer (1.12 (1.02 to 1.24); 13.4%, 11.9%); potassium metabisulfite with overall cancer (1.11 (1.03 to 1.20); 13.5%, 12.0%) and breast cancer (1.20 (1.04 to 1.38); 5.7%, 4.9%); sodium nitrite with prostate cancer (1.32 (1.02 to 1.70); 4.2%, 3.4%); potassium nitrate with overall cancer (1.13 (1.05 to 1.23); 14.0%, 12.0%) and breast cancer (1.22 (1.05 to 1.41); 5.9%, 4.8%); total acetates with overall cancer (1.15 (1.06 to 1.25); 14.3%, 12.2%) and breast cancer (1.25 (1.07 to 1.45); 6.1%, 4.9%); acetic acid with overall cancer (1.12 (1.01 to 1.25); 14.4%, 12.4%); and sodium erythorbate with overall cancer (1.12 (1.04 to 1.22); 13.5%, 11.9%) and breast cancer (1.21 (1.04 to 1.41); 5.7%, 4.8%). 11 of the 17 individually studied preservatives were not associated with cancer incidence. Conclusion: Multiple positive associations between intake of preservatives widely used in industrial foods and higher cancer incidence (overall, breast, and prostate) were observed in this large prospective cohort. Epidemiology based on health effect biomarkers and experimental research are needed to gain insight into outcome pathways. If confirmed, these new data call for the re-evaluation of regulations governing the food industry’s use of these additives, to improve consumer protection. In the meantime, the findings support recommendations for consumers to favour freshly made, minimally processed foods. Trial registration: ClinicalTrials.gov NCT03335644 .
Top Cited PapersOpen AccessIntake of food additive preservatives and incidence of cancer: results from the NutriNet-Santé prospective cohort
Objective: To investigate the association between intake of food additive preservatives and cancer incidence in a large prospective cohort. Design: Prospective cohort. Setting: French NutriNet-Santé cohort, 2009-23. Participants: 105 260 participants (≥15 years) without prevalent cancer who completed at least two 24 hour dietary records at baseline. Main outcome measures: Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed using repeated 24 hour dietary records and evaluated through multiple composition databases and ad hoc laboratory assays in food products for the most frequently consumed additive-food pairs. Associations between intake of three categories of preservatives (defined as sex specific thirds if preservative was consumed by at least a third of participants, otherwise defined as non-consumers and lower or higher consumers separated by the sex specific median) and cancer incidence were characterised using multivariable proportional hazards Cox models adjusted for potential confounders. Results: Mean age of participants was 42.0 years (standard deviation (SD 14.5) years), and 78.7% were women. 4226 participants received a diagnosis of incident cancer (mean follow-up 7.57 (SD 4.56) years), comprising 1208 breast, 508 prostate, 352 colorectal, and 2158 other cancers). Higher intakes of several preservatives were associated with higher cancer incidence: total non-antioxidants with overall cancer (hazard ratio for higher v non-consumers or lower consumers 1.16 (95% confidence interval (CI) 1.07 to 1.26); absolute risk of cancer at age 60 years, respectively, 13.3%, 12.1%) and breast cancer (1.22 (1.05 to 1.41); 5.7%, 4.8%); total sorbates, specifically potassium sorbate, with overall cancer (1.14 (1.04 to 1.24); 13.4%, 11.8%) and breast cancer (1.26 (1.07 to 1.49); 5.7%, 4.6%); total sulfites with overall cancer (1.12 (1.02 to 1.24); 13.4%, 11.9%); potassium metabisulfite with overall cancer (1.11 (1.03 to 1.20); 13.5%, 12.0%) and breast cancer (1.20 (1.04 to 1.38); 5.7%, 4.9%); sodium nitrite with prostate cancer (1.32 (1.02 to 1.70); 4.2%, 3.4%); potassium nitrate with overall cancer (1.13 (1.05 to 1.23); 14.0%, 12.0%) and breast cancer (1.22 (1.05 to 1.41); 5.9%, 4.8%); total acetates with overall cancer (1.15 (1.06 to 1.25); 14.3%, 12.2%) and breast cancer (1.25 (1.07 to 1.45); 6.1%, 4.9%); acetic acid with overall cancer (1.12 (1.01 to 1.25); 14.4%, 12.4%); and sodium erythorbate with overall cancer (1.12 (1.04 to 1.22); 13.5%, 11.9%) and breast cancer (1.21 (1.04 to 1.41); 5.7%, 4.8%). 11 of the 17 individually studied preservatives were not associated with cancer incidence. Conclusion: Multiple positive associations between intake of preservatives widely used in industrial foods and higher cancer incidence (overall, breast, and prostate) were observed in this large prospective cohort. Epidemiology based on health effect biomarkers and experimental research are needed to gain insight into outcome pathways. If confirmed, these new data call for the re-evaluation of regulations governing the food industry’s use of these additives, to improve consumer protection. In the meantime, the findings support recommendations for consumers to favour freshly made, minimally processed foods. Trial registration: ClinicalTrials.gov NCT03335644 .